Please assess the completion status of the following clinical trial:

Trial Title: The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Symptomatic leg ischemia by Rutherford Classification (category 1, 2, 3, 4 or 5); duration of intermittent claudication (category 1-3) should be at least 6 months~2. The patient should be suitable for percutaneous transluminal angioplasty (PTA) and also for stenting.~Exclusion Criteria:~1. Poor aortoiliac or common femoral inflow, which would be deemed inadequate to support a femoropopliteal bypass graft.~2. Patient having total occlusions or severe stenosis of the iliac artery on the same side must be excluded.~3. Gangrene in index limb (Rutherford category 6).

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Cordis SMART™ Nitinol Stent
- 2 (Type: ACTIVE_COMPARATOR): balloon angioplasty

Based on this trial design, predict the completion outcome and termination type (if applicable).